ANKE Artist AI De-noising Technology in Clinical Excellence

In the rapidly evolving field of medical imaging, ANKE has consistently positioned itself at the forefront of innovation. One of the most notable breakthroughs in recent years is the development of the Artist AI De-noising Technology. By leveraging advanced AI deep learning techniques, the Artist algorithm overcomes two major imaging challenges: poor image quality and significant noise at low radiation doses, and the severe plastic appearance caused by high-weight iterative reconstruction in traditional algorithms. This cutting-edge technology enables high-quality CT imaging while reducing patients' radiation exposure. Studies have shown that the use of the Artist technology during the scanning process can reduce the radiation dose by about 70-80%.The Artist technology sets new standards for image clarity, diagnostic accuracy, and patient safety. This article explores how the Artist algorithm is transforming various clinical applications across different patient populations.

1. Low-Dose Lung Cancer Screening Solution:

The National Comprehensive Cancer Network (NCCN) lung cancer screening guidelines advocate for effective screening to facilitate early detection of lung cancer. Data supports the use of low-dose computed tomography (LDCT) of the chest to screen high-risk lung cancer patients.

ANKE utilizes the Artist algorithm to achieve ultra-low-dose lung screening, combining advanced ASR high-resolution reconstruction technology with lung nodule analysis capabilities to ensure:

a. Preservation of fine pulmonary vessels and bronchi, enabling the accurate detection of subtle nodules and lesions.

b. Reducing noise of mediastina , making lymph nodes and masses more clearly visible.

c. Enhanced clarity of lung parenchyma, with sharp pleural edges, aiding in the identification of minor effusions and thickening, and allowing for precise assessment of interstitial lung disease.

This makes low-dose CT a safe and effective screening tool that significantly increases the success rate of early lung cancer detection while ensuring that radiation doses remain within a low range.

2. Accurate Soft Tissue Imaging Without Compromise:

In abdominal soft tissue scans, the most susceptible issue is the severe plastic appearance caused by high-weight iterative reconstruction. The Artist algorithm preserves the intricate details of renal structures and vascular details, reduces noise in the pelvic area, and ensures that soft tissue masses and lymph nodes are more clearly visible, facilitating the accurate detection of small lesions and abnormalities.

3. Stroke Solutions:

ANKE’s stroke solutions include a one-stop stroke examination and one-click hemorrhage analysis. Utilizing the Adose technology, ANKE captures images at ultra-low mA levels. Combined with the Artist technology, ensures precise perfusion data is obtained even at low doses.

Today, the Artist AI De-noising Technology, integrated across ANKE's entire CT platform, represents the latest technological advancement in dose reduction for CT. The Artist AI De-noising Technology is designed to enhance image quality while increasing confidence in image interpretation across various clinical applications, including head, whole-body, and cardiovascular imaging, making it suitable for patients of all ages.

Through extensive optimization for multiple clinical application scenarios, the?Artist AI De-noising Technology excels in complex clinical environments, underscoring ANKE's leadership in driving innovation in medical imaging technology. Through the application of this technology, ANKE is paving the way for the future of precision medicine, empowering doctors to provide more reliable diagnoses and care for patients.